Alamar Biosciences, Inc. Stock: price and insider trades · United States

This page follows insider dealings at Alamar Biosciences, Inc. as filed with SEC (Form 4). In the past year (18 October 2025 to 18 October 2026), 49 filings came from 13 insiders.

No insider sold shares on the market over the period. Instead, the filings list 1 purchase totalling €3.4M, made by 1 insider. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 1 major shareholder. Illumina Innovation Fund II GP, L.L.C. filed the largest purchase, €3.4M, on 20 April 2026.

In the case of 1 purchase, another manager of the company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last purchase on record was published on 20 April 2026, which is 181 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade.

Across the 5,808 companies tracked on its exchange, the median is 19 filings; at 49 filings, this issuer sits above that mark. Over the whole record (from 2026), the tally stands at 1 purchase and no sales.

For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.